Cargando…

Immune monitoring technology primer: immunosequencing

BACKGROUND: Profiling of the immune receptor repertoire is becoming increasingly relevant to the understanding and clinical management of cancer, autoimmunity, aging, and infectious disease. FINDINGS: A platform technology is described that provides comprehensive immune receptor profiling. CONCLUSIO...

Descripción completa

Detalles Bibliográficos
Autor principal: Kirsch, Ilan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480450/
https://www.ncbi.nlm.nih.gov/pubmed/26113978
http://dx.doi.org/10.1186/s40425-015-0076-y
_version_ 1782378162839093248
author Kirsch, Ilan
author_facet Kirsch, Ilan
author_sort Kirsch, Ilan
collection PubMed
description BACKGROUND: Profiling of the immune receptor repertoire is becoming increasingly relevant to the understanding and clinical management of cancer, autoimmunity, aging, and infectious disease. FINDINGS: A platform technology is described that provides comprehensive immune receptor profiling. CONCLUSION: Immunosequencing is a platform technology that allows the enumeration, specification and quantification of each and every B-and/or T-cell in any biologic sample of interest. It is based on bias-controlled multiplex PCR and high throughput sequencing and is highly accurate, standardized, and sensitive.
format Online
Article
Text
id pubmed-4480450
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44804502015-06-26 Immune monitoring technology primer: immunosequencing Kirsch, Ilan J Immunother Cancer Short Report BACKGROUND: Profiling of the immune receptor repertoire is becoming increasingly relevant to the understanding and clinical management of cancer, autoimmunity, aging, and infectious disease. FINDINGS: A platform technology is described that provides comprehensive immune receptor profiling. CONCLUSION: Immunosequencing is a platform technology that allows the enumeration, specification and quantification of each and every B-and/or T-cell in any biologic sample of interest. It is based on bias-controlled multiplex PCR and high throughput sequencing and is highly accurate, standardized, and sensitive. BioMed Central 2015-06-25 /pmc/articles/PMC4480450/ /pubmed/26113978 http://dx.doi.org/10.1186/s40425-015-0076-y Text en © Kirsch. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Short Report
Kirsch, Ilan
Immune monitoring technology primer: immunosequencing
title Immune monitoring technology primer: immunosequencing
title_full Immune monitoring technology primer: immunosequencing
title_fullStr Immune monitoring technology primer: immunosequencing
title_full_unstemmed Immune monitoring technology primer: immunosequencing
title_short Immune monitoring technology primer: immunosequencing
title_sort immune monitoring technology primer: immunosequencing
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480450/
https://www.ncbi.nlm.nih.gov/pubmed/26113978
http://dx.doi.org/10.1186/s40425-015-0076-y
work_keys_str_mv AT kirschilan immunemonitoringtechnologyprimerimmunosequencing